mRNA booster immunisations protect against Covid-19 for 4-5 months: study
The findings, published in The BMJ, found that in the Omicron period mRNA vaccine protection against severe Covid-19 was initially high (89 per cent) but waned after primary vaccination.
"In our new study, we looked at tens of thousands of patients in multiple states, seen over a year and a half," said researcher Brian Dixon from Indiana University.
"Our analysis provides compelling evidence, both of the effectiveness of boosting to increase immunity, and that this immunity begins to wane after four or five months, indicating additional booster doses are necessary," Dixon added.
For the study, the team analysed data from patients seen at 261 hospitals, 272 emergency departments and 119 urgent care clinics in 10 states across the US from January 17, 2021, to July 12, 2022.
The data covered periods of Omicron dominance (including subvariants BA.4 and BA.5), as well as the previous periods of Delta and pre-Delta dominance.
Focusing on the durability of boosters against hospitalisation, the study found that effectiveness increased markedly after a booster shot, waning again about four to five months after the booster.
Protection increased again following a second booster. The protection and waning pattern with Moderna and Pfizer boosters were similar.
Railways increased the speed of 500 mail express trains by 10-70 minutes
"Naya Jammu & Kashmir" celebrates a rejuvenated global sericulture industry
Popular on BI
- Digital Marketing Strategies
- Sensex, Nifty soar in early trade on impressive GDP data, foreign fund inflows
- Cabinet approves royalty rates for mining of 12 critical minerals
- Paytm and Paytm Payments Bank mutually agree to discontinue various inter-company agreements
- Platinum Industries IPO allotment – How to check allotment, GMP, listing date and more